Literature DB >> 3335077

Lymphokine-activated killer cell lysis of human neuroblastoma cells: a model for purging tumor cells from bone marrow.

E W Ades1, N Peacocke, H Sabio.   

Abstract

Evidence is presented that neuroblastoma tumor cells in host bone marrow is susceptible to autologous lymphokine-activated killer cells (LAK). Thus, immunologic purging of bone marrow with LAK may be considered as a tool in the arsenal of bone marrow purging-for autologous bone marrow transplantation.

Entities:  

Mesh：

Year:  1988        PMID： 3335077     DOI： 10.1016/0090-1229(88)90015-3

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


  2 in total

1.  Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group.

Authors:  Andrew L Gilman; M Fevzi Ozkaynak; Katherine K Matthay; Mark Krailo; Alice L Yu; Jacek Gan; Adam Sternberg; Jacquelyn A Hank; Robert Seeger; Gregory H Reaman; Paul M Sondel
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

2.  Lymphokine-activated killer cytotoxicity against leukaemic blast cells.

Authors:  J A Tratkiewicz; J Szer; R L Boyd
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.